2-methoxyestradiol, an endogenous estrogen metabolite, induces apoptosis in endothelial cells and inhibits angiogenesis: Possible role for stress-activated protein kinase signaling pathway and Fas expression

被引:178
作者
Yue, TL [1 ]
Wang, XK [1 ]
Louden, CS [1 ]
Gupta, S [1 ]
Pillarisetti, K [1 ]
Gu, JL [1 ]
Hart, TK [1 ]
Lysko, PG [1 ]
Feuerstein, GZ [1 ]
机构
[1] SMITHKLINE BEECHAM PHARMACEUT,DEPT TOXICOL,KING OF PRUSSIA,PA 19406
关键词
D O I
10.1124/mol.51.6.951
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
2-methoxyestradiol (2-ME) is an endogenous metabolite of estradiol-17 beta and the oral contraceptive agent 17-ethylestradiol. 2-ME was recently reported to inhibit endothelial cell proliferation. The current study was undertaken to explore the mechanism of 2-ME effects on endothelial cells, especially whether 2-ME induces apoptosis, a prime mechanism in tissue remodeling and angiogenesis. Cultured bovine pulmonary artery endothelial cells (BPAEC) exposed to 2-ME showed morphological (including ultrastructural) features characteristic of apoptosis: cell shrinkage, cytoplasmic and nuclear condensation, and cell blebbing. 2-ME-induced apoptosis in BPAEC was a time- and concentration-dependent process (EC50 = 0.45 +/- 0.09 mu M, n = 8). Nucleosomal DNA fragmentation in BPAEC treated with 2-ME was identified by agarose gel electrophoresis (DNA ladder) as well as in situ nick end labeling. Under the same experimental conditions, estradiol-17 beta and two of its other metabolites, estriol and 2-methoxyestriol (less than or equal to 10 mu M), did not have an apoptotic effect on BPAEC. 2-ME activated stress-activated protein kinase (SAPK)/c-Jun amino-terminal protein kinase in BPAEC in a concentration-dependent manner. The activity of SARK was increased by 170 +/- 27% and 314 +/- 22% over the basal level in the presence of 0.4 and 2 mu M 2-ME (n = 3-6), respectively. The activation of SAPK was detected at 10 min, peaked at 20 min, and returned to basal levels at 60 min after exposure to 2-ME. Inhibition of SAPK/c-Jun amino-terminal protein kinase activation by basic fibroblast growth factor, insulin-like growth factor, or forskolin reduced 2-ME-induced apoptosis. Immunohistochemical analysis of BPAEC indicated that 2-ME up-regulated expression of both Fas and Bcl-2. In addition, 2-ME inhibited BPAEC migration (IC50 = 0.71 +/- 0.11 mu M, n = 4) and basic fibroblast growth factor-induced angiogenesis in the chick chorioallantoic membrane model. Taken together, these results suggest that promotion of endothelial cell apoptosis, thereby inhibiting endothelial cell proliferation and migration, may be a major mechanism by which 2-ME inhibits angiogenesis.
引用
收藏
页码:951 / 962
页数:12
相关论文
共 46 条
[1]   CONCENTRATIONS OF 2-METHOXYESTROGENS IN HUMAN-SERUM MEASURED BY A HETEROLOGOUS IMMUNOASSAY WITH AN I-125-LABELED LIGAND [J].
BERG, D ;
SONSALLA, R ;
KUSS, E .
ACTA ENDOCRINOLOGICA, 1983, 103 (02) :282-288
[2]   APPROACHES TO STUDYING CELL-ADHESION MOLECULES IN ANGIOGENESIS [J].
BISCHOFF, J .
TRENDS IN CELL BIOLOGY, 1995, 5 (02) :69-74
[3]   INTEGRIN ALPHA(V)BETA(3) ANTAGONISTS PROMOTE TUMOR-REGRESSION BY INDUCING APOPTOSIS OF ANGIOGENIC BLOOD-VESSELS [J].
BROOKS, PC ;
MONTGOMERY, AMP ;
ROSENFELD, M ;
REISFELD, RA ;
HU, TH ;
KLIER, G ;
CHERESH, DA .
CELL, 1994, 79 (07) :1157-1164
[4]   A NEW CLASS OF STEROIDS INHIBITS ANGIOGENESIS IN THE PRESENCE OF HEPARIN OR A HEPARIN FRAGMENT [J].
CRUM, R ;
SZABO, S ;
FOLKMAN, J .
SCIENCE, 1985, 230 (4732) :1375-1378
[5]   2-METHOXYESTRADIOL, AN ENDOGENOUS MAMMALIAN METABOLITE, INHIBITS TUBULIN POLYMERIZATION BY INTERACTING AT THE COLCHICINE SITE [J].
DAMATO, RJ ;
LIN, CM ;
FLYNN, E ;
FOLKMAN, J ;
HAMEL, E .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (09) :3964-3968
[6]   JNK1 - A PROTEIN-KINASE STIMULATED BY UV-LIGHT AND HA-RAS THAT BINDS AND PHOSPHORYLATES THE C-JUN ACTIVATION DOMAIN [J].
DERIJARD, B ;
HIBI, M ;
WU, IH ;
BARRETT, T ;
SU, B ;
DENG, TL ;
KARIN, M ;
DAVIS, RJ .
CELL, 1994, 76 (06) :1025-1037
[7]   CONTROLLING THE VASCULATURE - ANGIOGENESIS, ANTI-ANGIOGENESIS AND VASCULAR TARGETING OF GENE-THERAPY [J].
FAN, TPD ;
JAGGAR, R ;
BICKNELL, R .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1995, 16 (02) :57-66
[8]  
FOLKMAN J, 1992, J BIOL CHEM, V267, P10931
[9]  
FOTSIS T, 1994, NATURE, V368, P237, DOI 10.1038/368237a0
[10]   EXCRETION OF 5 DIFFERENT 2-HYDROXYOESTROGEN MONOMETHYL ETHERS IN HUMAN PREGNANCY URINE [J].
GELBKE, HP ;
KNUPPEN, R .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1976, 7 (6-7) :457-463